Gen Incode
Oxford, GB · 2 known investors
Find your way into Gen Incode
GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.
Investors · 2
Frequently asked questions
- What does Gen Incode do?
- GENinCode provides genomic testing for cardiovascular disease prevention and diagnosis using monogenic and polygenic risk assessment to identify patient risk and enable targeted preventive treatment. The company also offers testing for ovarian cancer surveillance, leveraging its proprietary software platform to combine genetic profiles with clinical risk factors.
- Who are Gen Incode's investors?
- Gen Incode's investors include Maven Capital Partners, Cambridge Innovation Capital.
- Where is Gen Incode headquartered?
- Gen Incode is headquartered in Oxford, GB.